Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03955783 |
| Title | Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Michael Byrne |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Roswell Park Cancer Center | Buffalo | New York | 14263 | United States | Details | |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | United States | Details | |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8565 | United States | Details |